Key result
Maximal strength training significantly improved overall quality of life (p = 0.002, d = 0.9) and increased maximal muscle strength by 20% compared to standard care in women undergoing treatment for breast cancer.
Why the study?
Breast cancer patients lose muscle strength during adjuvant treatment, but the effect of maximal strength training on their quality of life remains elusive.
Does maximal strength training improve quality of life and muscle strength in women with newly diagnosed breast cancer undergoing treatment?
RCT (n=55)
Open-label
Randomized
No
Does maximal strength training improve quality of life and muscle strength in women with newly diagnosed breast cancer undergoing treatment?
Standardized Mean Difference: 0.9
Absolute Event Rate: 76.2% vs 63.5%
p-value: p=0.002
Maximal strength training significantly improves muscle strength and overall quality of life while reducing fatigue in women undergoing treatment for breast cancer.
Supports integrating maximal strength training into breast cancer care; confirms QoL and strength benefits in RCT.
Cancer rehabilitation programs mainly involve endurance cardio training while little attention has been paid to strength training. Breast cancer (BC) patients lose muscle strength while undergoing adjuvant treatment, thus affecting daily activities and quality of life. Maximal strength training, with an emphasis on velocity in the concentric phase, improves maximal strength and muscle force development characteristics. However, the effect of maximal strength training on quality of life for BC patients undergoing treatment remains elusive. Consequently, the aim of this study was to evaluate the effectiveness of maximal strength training in Health related quality of life in women with newly diagnosed BC. MATERIALS AND METHODS: 55 BC patients with disease stage I-III were randomized into a training group and control group. The training group performed maximal strength training twice a week for 3 months, whereas the control group followed prescribed treatment without strength training. Overall quality of life was measured by The European Organization for Research and Treatment of Cancer Core Quality of life Questionnaire-C30 and additional BC module BR23 before and after the intervention. RESULTS: The results obtained from pre-tests and those obtained after 3 months of intervention revealed that patients in the training group significantly increased one repetion maximum, by 20.4 kg (20%) (p = 0.001, d = 0.9). Simultaneously, statistically significant alterations were observed in this variable for the control group, one repetition maximum decreased by 8.9 kg (9%) (p = 0.001, d = 0.5). The overall quality of life improved significantly by 13% for the training group with large effect (p = 0.002, d = 0.6), but no relevant changes were observed in the control group (p = 0.44, d = 0.2). Results revealed remarkable changes in overall quality of life after 3-month post-test period between the two groups with large effect (p = 0.002, d = 0.9). The training sessions had helped in diminishing the sense of fatigue by 24% (p = 0.03, d = 0.6), while it had got worse by 25% (p = 0.02, d = 0.4) for the control group. Again, the data on large effect were noticed to differ between the groups (p = 0.01, d = 0.6). CONCLUSION: Maximal strength training for BC patients was well tolerated, safe and feasible and showed strength improvements that led to improved muscle strength and improved overall quality of life. These data certainly support the therapeutic role for maximal strength training in the treatment of BC.
No takes yet. Share an insight, caveat, or question.
Cešeiko et al. (2019) conducted an RCT in Breast cancer (n=55). Maximal strength training vs. Standard care without strength training was evaluated on Overall quality of life (EORTC QLQ-C30 Global health status) (d = 0.9, p=0.002). Maximal strength training significantly improved overall quality of life (p = 0.002, d = 0.9) and increased maximal muscle strength by 20% compared to standard care in women undergoing treatment for breast cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: